📣 VC round data is live. Check it out!

Welby Valuation Multiples

Discover Welby's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like ImExHS, MedApp, Physitrack, Metacare and more.

Welby Overview

About Welby

Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.


Founded

2011

HQ

Japan

Employees

48

Website

welby.jp

Financials (LTM)

Revenue: $4M
Net Income: ($4M)

EV

$14M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Welby Financials

Welby reported last 12-month revenue of $4M.

In the same LTM period, Welby generated had net loss of ($4M).

Revenue (LTM)


Welby P&L

In the most recent fiscal year, Welby reported revenue of $4M and EBITDA of ($3M).

Welby is unprofitable as of last fiscal year, with gross margin of 68%, EBITDA margin of (76%), and net margin of (82%).

See analyst estimates for Welby
LTMLast FY202320242025202620272028
Revenue$4M$4M$4M$3M$4M
Gross Profit-$3M$2M$2M$3M
Gross Margin-68%65%72%71%
EBITDA-($3M)($3M)($5M)($3M)
EBITDA Margin-(76%)(87%)(150%)(79%)
EBIT Margin(71%)(69%)(76%)(124%)(71%)
Net Profit($4M)($3M)($3M)($5M)($3M)
Net Margin(85%)(82%)(88%)(152%)(85%)

Financial data powered by Morningstar, Inc.

Welby Stock Performance

Welby has current market cap of $14M, and enterprise value of $14M.

Market Cap Evolution


Welby's stock price is $1.65.

Welby share price decreased by 3.9% in the last 30 days, and by 25.6% in the last year.

Welby has an EPS (earnings per share) of $-0.40.

See more trading valuation data for Welby
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$14M$14M-0.2%-3.9%-18.5%-25.6%$-0.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Welby Valuation Multiples

Welby trades at 3.4x EV/Revenue multiple, and (4.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Welby

EV / Revenue (LTM)


Welby Financial Valuation Multiples

As of June 3, 2026, Welby has market cap of $14M and EV of $14M.

Welby has a P/E ratio of (4.0x).

LTMLast FY202320242025202620272028
EV/Revenue3.4x3.4x3.9x4.2x3.5x
EV/EBITDA-(4.5x)(4.5x)(2.8x)(4.5x)
EV/EBIT(4.8x)(5.0x)(5.1x)(3.4x)(5.0x)
EV/Gross Profit-5.0x6.0x5.9x5.0x
P/E(4.0x)(4.1x)(4.4x)(2.8x)(4.1x)
EV/FCF-(5.2x)(8.7x)(2.9x)(5.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Welby Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Welby Margins & Growth Rates

In the most recent fiscal year, Welby reported gross margin of 68%, EBITDA margin of (76%), and net margin of (82%).

See estimated margins and future growth rates for Welby

Welby Margins

Last FY20242025202720282029
Gross Margin68%72%71%
EBITDA Margin(76%)(150%)(79%)
EBIT Margin(69%)(124%)(71%)
Net Margin(82%)(152%)(85%)
FCF Margin(65%)(147%)(68%)

Welby Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(8%)20%
Gross Profit Growth1%18%
EBITDA Growth59%(37%)
EBIT Growth50%(31%)
Net Profit Growth59%(33%)
FCF Growth200%(45%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Welby Operational KPIs

Welby's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Welby
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.1M---
Opex to Revenue136%141%196%142%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Welby Competitors

Welby competitors include ImExHS, MedApp, Physitrack, Metacare, CurveBeam AI, NRGene, Vidavo, iXensor, Media Lab and MRSO.

Most Welby public comparables operate across Digital Therapeutics, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
ImExHS0.6x0.5x10.0x8.3x
MedApp14.0x-56.5x-
Physitrack0.9x1.1x(7.2x)19.7x
Metacare2.2x-13.1x-
CurveBeam AI2.9x3.2x(3.5x)(3.5x)
NRGene1.8x-(5.8x)-
Vidavo3.9x-10.3x-
iXensor10.8x-(7.3x)-

This data is available for Pro users. Sign up to see all Welby competitors and their valuation data.

Start Free Trial

Welby VC Funding History

Before going public, Welby raised $11M in total equity funding, across 4 rounds.


Welby Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Dec-17Series ADigital Garage; Japan Post Capital$9M-Welby Inc., founded in 2011 and based in Tokyo, Japan, specializes in providing digital tools that aid patients and their families in managing medical treatment and preventing disease progression. The company offers services including marketing support for pharmaceuticals and health insurance societies, as well as government entities through its digital service platform. Welby provides an app called Welby My Karte, which allows patients to share health data with healthcare professionals and family members in a visualized format. Additionally, the company engages in medical data research services and collaborates with pharmaceuticals, medical device companies, governments, patients, and healthcare professionals to co-develop and provide digital services. Digital Garage participated in Welby's venture round in 2017.
Mar-16Pre-seedSuneight Investment$300K--
Dec-15SeedDG VENTURES$2M--
Apr-14Pre-seedDentsu Innovation Partners$300K--

Acquisitions by Welby

Welby has acquired 1 company to date.

Last acquisition by Welby was on April 9th 2024. Welby acquired Medaca for $1M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Welby

Medaca
Description
Medaca is a Tokyo-based developer of cloud, mobile, and web services for centralized health data management. Its platform aggregates patient records, lab results, and imaging from multiple providers, enabling secure sharing among Japanese hospitals and clinics. The system complies with national privacy laws for telemedicine and population health analytics.
HQ CountryJapan
HQ City
Tokyo
Deal Date9 Apr 2024
Valuation$1M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Welby acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Welby

Welby has invested in 1 company to date.

Latest investment by Welby was on August 9th 2023. Welby invested in Rehasaku in their $1M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Welby

Rehasaku
Description
Rehasaku is a Tokyo-based platform supporting physiotherapists, judo therapists, and patients through digital tools for rehabilitation tracking and exercise guidance. The service provides video libraries of judo rehabilitation techniques, progress analytics, and remote consultations, used by clinics in Japan. Rehasaku integrates with wearable sensors for real-time data, aiding recovery from sports injuries and orthopedic conditions in partnership with judo federations.
HQ CountryJapan
HQ City
Tokyo
Deal Date9 Aug 2023
RoundSeed
Raised$1M
InvestorsANRI; DNX Ventures; Welby
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Welby investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Welby

When was Welby founded?Welby was founded in 2011.
Where is Welby headquartered?Welby is headquartered in Japan.
How many employees does Welby have?As of today, Welby has over 48 employees.
Is Welby publicly listed?Yes, Welby is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Welby?Welby trades under 4438 ticker.
When did Welby go public?Welby went public in 2019.
Who are competitors of Welby?Welby main competitors include ImExHS, MedApp, Physitrack, Metacare, CurveBeam AI, NRGene, Vidavo, iXensor, Media Lab, MRSO.
What is the current market cap of Welby?Welby's current market cap is $14M.
What is the current revenue of Welby?Welby's last 12 months revenue is $4M.
What is the current EV/Revenue multiple of Welby?Current revenue multiple of Welby is 3.4x.
Is Welby profitable?No, Welby is not profitable.
What is the current net income of Welby?Welby's last 12 months net income is ($4M).
How many companies Welby has acquired to date?As of June 2026, Welby has acquired 1 company.
What was the largest acquisition by Welby?$1M acquisition of Medaca on 9th April 2024 was the largest M&A Welby has done to date.
What companies Welby acquired?Welby acquired Medaca.
In how many companies Welby has invested to date?As of June 2026, Welby has invested in 1 company.
What was the last Welby investment?On 9th August 2023 Welby invested in Rehasaku, participating in a $1M Seed round, alongside ANRI and DNX Ventures.
In what companies Welby invested in?Welby invested in Rehasaku.

See public comps similar to Welby

Lists including Welby

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial